| ARCHIVE
OF RESEARCH PUBLICATIONS EQUINE PHARMACOLOGY, THERAPEUTICS, AND TOXICOLOGY LABORATORY, GLUCK EQUINE RESEARCH CENTER, UNIVERSITY OF KENTUCKY Search for specific topics using your web browser's search function. |
|
| 001 | Recovery of procaine from biological fluids. Res Commun Chem Path Pharmacol. 11(2): 187-94, 1975 |
| 002 | The pharmacology of procaine in the horse. I. A preliminary report. Am J Vet Res, 37:1107-1110, 1976. |
| 003 | The pharmacology of procaine in the horse II. The procaine esterase properties of equine plasma and synovial fluid. Am J Vet Res, 37:1165-1170, 1976. |
| 004 | The pharmacology of procaine in the horse. III. Evidence against the existence of a procaine-penicillin complex. Am J Vet Res, 38:437-442, 1977. |
| 005 | The pharmacology of procaine in the horse: Pharmacokinetics and behavioral effects. Am J Vet Res, 38:637-647, 1977. |
| 006 | Drug interactions in the horse. I. Effects of chloramphenicol, quinidine and oxyphenbutazone on phenylbutazone metabolism. Am J Vet Res, 38:123-127, 1977. |
| 007 | Electron capture detection of an apomorphine-heptafluorobutyrate derivative at low picogram levels. Res Commun Chem Path Pharmacol, 15(3):447-455, 1976. |
| 008 | Biochemical and behavioral effects of reserpine in the horse. Presented at the 2nd Equine Pharmacology Symposium, Ohio State University , Columbus , OH , 1978. |
| 009 | Drug interactions in the horse. Effect of furosemide on plasma and urine levels of phenylbutazone. Res Comun Chem Path Pharmacol. 15(2):257-64, 1976 |
| 010 | A review of the pharmacology of furosemide in the horse. Proc 3rd Int’l Equine Doping Conference, Rome, March 1977. Atti Della Conferenza Int’l Sul Doping, pp 323-352, 1978. |
| 011 | Gas liquid chromatography and electron capture detection in equine drug testing. |
| 012 | Pine-oil toxicity in the horse: Drug detection, residues and pathological changes. Res Commun Chem Path Pharmacol 15:291-301, 1976. |
| 013 | Drugs, Horses and the Kentucky Equine Drug Research Program. Proc 2nd Conv Natn'l Assoc. State Racing Commissioners, San Diego, CA, 1976, pp 89-99. |
| 014 | Use of Bumetanide in Horses. Letter. Amer J Vet Res March 1977 |
| 015 | The pharmacology of procaine in the horse V. Relationships between plasma and urinary concentrations of procaine. J Eq Med Surg, 1:188-194, 1977. |
| 016 | Phenylbutazone (Butazolidin) in horses: A review. J Eq Med Surg, 1:221-225, 1977. |
| 017 | Furosemide (Lasix) in horses: A review. J Eq Med Surg, 1:215-218, 1977. |
| 018 | Drug interactions in the horse. III. Effects of furosemide on urinary concentrations of glucuronide metabolites of pentazocine. Res Commun Chem Path Pharmacol, 17;447-456, 1977. |
| 019 | Interaction of ouabain and cassaine with Na++K+-ATPase and its relationship to their inotropic actions. In: Drug Action at the Molecular Level, MacMillan Pub Co, London , 1977, pp 213-133. |
| 020 | Pharmacokinetics and behavorial effects of methylphenidate in Throughbred horses. Am J Vet Res 47(5):722-26, |
| 021 | Furosemide (Lasix®) in the horse: An overview. Proc 23rd Annual Conv AAEP, Vancouver , 1977, pp 419-421. |
| 022 | The pharmacology of furosemide in the horse. I. Effects on the disposition of procaine, methylphenidate, phenylbutazone and pentazocine. J Eq Med Surg, 1:402-409, 1978. |
| 023 | The pharmacology of furosemide in the horse. II. Its detection, pharmacokinetics and clearance from urine. J Eq Med Surg, 2:185-194, 1978. |
| 024 | The pharmacology of furosemide in the horse. III. Its detection, pharmacokinetics and clearance from urine. J Eq Med Surg |
| 025 | Furosemide in the horse: an overview, 23rd AAEP |
| 026 | The anabolic steroid androgen group of drugs. J Eq Med Surg, 2:163-165, 1978. |
| 027 | The pharmacology of narcotic analgesics in the horse. I. The detection, pharmacokinetics and urinary "clearance times" of pentazocine. J Eq Med Surg, 3(4):191-198, 1979. |
| 028 | Effects of monovalent cations on Na++K+-ATPase in rat brain slices. Europ J Pharmacol, 55:281-292, 1979 |
| 029 | A review of the pharmacology of procaine in the horse. J Eq Med Surg, 2:209, 213-214, 1978. |
| 030 | The pharmacology of reserpine in the horse. I. Effects of reserpine and imipramine on platelet uptake of serotonin, in vitro and in vivo. J Eq Med Surg 3(7):325-330, 1979. |
| 031 | The pharmacology of narcotic analgesics in the horse. II. Studies on the detection, pharmacokinetics, urinary clearance times and behavioral effects of pentazocine and fentanyl in the horse. Irish Vet J, 33:169-176, 1979. |
| 032 | Narcotic analgesics and the opiate receptor in the horse. J Eq Med Surg, 2:397-399, 1978. |
| 033 | Plasma and urinary drug concentrations, drug "clearance times", and pharmacological effects. J Eq Med Surg, 2(6):262-267, 1978. |
| 034 | A review of the pharmacology of reserpine in the horse. J Eq Med Surg, 2(10):433-438, 1978. |
| 035 | Chemotherapy in the horse: The penicillins. J Eq Med Surg, 2(11):475-479, 1978. |
| 036 | A modified Folin-Denis over-spray for the detection of phenolic alkaloidal drugs. Irish Vet J, pp 209-213, December 1978. |
| 037 | An evaluation of pre- and post-race testing and blood and urine drug testing in horses. J Eq Med Surg, 3(2):85-90, 1979. |
| 038 | The pharmacology of narcotic analgesics in the horse. III. Characteristics of the locomotor effects of fentanyl and apomorphine. J Eq Med Surg, 3(6):284-288, 1979. |
| 039 | The pharmacology of narcotic analgesics in the horse. IV. Dose and time response relationships for behavioral responses to morphine, meperidine, pentazocine, anileridine, methadone, and hydromorphone. J Eq Med Surg, 3:377-385, 1979. |
| 040 | Quantitation and selective blockade of response to narcotic analgesics in the horse. 2nd Equine Pharmacology Symposium, The Ohio State University , Columbus pp 183-188, 1978. |
| 041 | The detection, identification and basic pharmacology of furosemide in the horse. 2nd Equine Pharmacology Symposium, the Ohio State University , Columbus , pp 43-57, 1978. |
| 042 | The pharmacology of reserpine in the horse. II. Effects of reserpine on platelet serotonin uptake and behavior. J Eq Med Surg, 3:446-451, 1979. |
| 043 | Drugs and performance testing in racing horses. Report of NASRC Veterinary Chemists Advisory Committee, March 27, 1979 . NASRC Proceedings, San Francisco, 85-106, 1979. |
| 044 | Pharmacology Review: Testing for drugs in horses. J Eq Med Surg, 2(12):518-524, 1978. |
| 045 | Pharmacology Review: The corticosteroids. J Eq Med Surg, 3(1):10-15, 1979. |
| 046 | Pharmacology of narcotic analgesics in the horse. Selective blockade of narcotic-induces locomotor activity. Am J Vet Res 42(7):16-721, 1981. |
| 047 | Pharmacology Review: Actions of central stimulant drugs in the horse. I. J Eq Med Surg, 3(2):60-66, 1979. |
| 048 | Pharmacology Review: Actions of central stimulant drugs in the horse. II. J Eq Med Surg, 3(3):102-109, 1979. |
| 049 | Pharmacology Review: Drug metabolism and elimination in the horse. J Eq Med Surg, 3(3):150-156, 1979. |
| 050 | Pharmacology Review: A review of recent research on furosemide in the horse. J Eq Med Surg, 2:314, 320-321, 1978. |
| 051 | Variable-interval responding in the horse: A sensitive method of quantitating effects of centrally acting drugs. Am J Vet Res, 43(7):1143-1146, 1982. |
| 052 | Pharmacology Review: Streptomycin, gentamicin, and the amino-glycoside antibiotics. J Eq Med Surg, 2:206-212, 1979. |
| 053 | Pharmacology Review: The non-steroidal anti-inflammatory drugs. I. Phenylbutazone. J Eq Med Surg, 3:253-258, 1979. |
| 054 | Drugs, Racehorses and the Kentucky Drug Research Program. The Blood-Horse, Vol CII(14):1453-1455, April 1976. |
| 055 | Pharmacology Review: The non-steroidal anti-inflammatory drugs. II. Equiproxin, meclofenamic acid, flunixin and others. J Eq Med Surg, 3(7):298-392, 1979. |
| 056 | Pharmacology Review: The phenothiazine "tranquilizers." J Eq Med Surg, 3:460-466, 1979. |
| 057 | Medication of performance horses. In: Equine Medicine and Surgery, Am Vet Pub, Inc, Santa Barbara , CA , 1982, pp 158-172. |
| 058 | Variable interval conditioning in the horse: A sensitive measure of behavior. Proc 3rd Int’l Symposium on Equine Medication Control, Lexington , June 1979, pp 367-379. |
| 059 | The pharmacokinetics and behavioral effects of fentanyl and other narcotic analgesics in the horse. Proc 3rd Int’l Symposium on Equine Medication Control, Lexington , June 1979, pp 311-321. |
| 060 | An overview of the major antibiotics in equine medicine. Proc 26th Annual Conf AAEP, Anaheim , CA , December 1980, pp 491-502. |
| 061 | Atypical conditions for qualitative recovery of acepromazine and chlorpromazine from plasma. J Toxic & Environmntl Hlth, 7:745-751, 1981. |
| 062 | Current Status of Drug Receptor theory with specific reference to Na/K-ATPase and opiate receptors. Proc 2nd Symp Vet Pharm & Therap. 1980 |
| 063 | Pharmacology of corticosteroid therapy in the horse. Proc 26th Annual Conf AAEP, Anaheim , CA , December 1980, pp 411-415. |
| 064 | The pharmacology and therapeutics of exercise-induced pulmonary hemorrhage (EIPH). Proc 26th Annual Conf AAEP, Anaheim , CA , December 1980, pp 435-440. |
| 065 | The pharmacology of narcotic analgesics in the horse: Quantitative detection of morphine in equine blood and urine and logit-log transformations of this data. Am J Vet Res 42(9):1523-1530, 1981. |
| 066 | Recovery of acepromazine from equine plasma and its pharmacology in the horse. Proc 4th Int’l Symposium on Equine Medication Control, 1981. |
| 067 | Morphine-glucuronide hydrolysis: Superiority of glucuronidase from Patella vulgata. Clin Chem, 28(1):83-86, 1982. |
| 068 | The pharmacology of furosemide in the horse. IV. The duration of reduction of urinary concentration of drugs. J Equine Vet Sci, 1:203-207, 1981. |
| 069 | Phenylbutazone and other drugs in horses racing under a controlled medication program. Proc 4th Int’l Symposium on Equine Medication Control, Melbourne , Australia , May 1981, pp 68-73. |
| 070 | Furosemide, Patella vulgata b-glucuronidase and drug analysis: Conditions for enhancement of the TLC detection of apomorphine, butorphanol, hydromorphone, nalbuphine, oxymorphone and pentazocine in equine urine. Res Comm in Chem Pathol Pharmacol 35(1):27-41, 1982. |
| 071 | Drug "clearance times" and "detection times" in horses: A reappraisal. J Vet Pharmacol Therap, 5:195-197, 1982. |
| 072 | Inability of goldenseal to interfere with the detection of morphine in urine. J Equine Vet Sci, 2(1):16-19, 1981. |
| 073 | Performance testing in the horse: A review of the role of simple behavioral models in the design of performance experiments. J Vet Pharmacol Therap, 5:105-118, 1982. |
| 074 | Pharmacology, pharmacokinetics, and behavioral effects of acepromazine in the horse. Proc 4th Int’l Conf Control Drugs in Racehorses, Melbourne , Australia , May 1981, pp 81-86. |
| 075 | Drugs and the Performance Horse. Charles C. Thomas, Springfield , IL , 1981. |
| 076 | Pharmacokinetics and protein binding of morphine in horses. Am J Vet Res, 44(5):870-874, 1983. |
| 077 | Some reflections on positive results from medication control tests in the USA. Eq Vet J, 16:43-46, 1984. |
| 078 | The pharmacokinetics, pharmacological responses, and behavioral effects of acepromazine in the horse. J Vet Pharmacol Therap, 5:21-31, 1982. |
| 079 | The effects of naloxone on endotoxic and hemorrhagic shock in horses. Res Commun Chem Path Pharmacol, 44(2):227-238, 1984. |
| 080 | Effects of enkephalins versus opiates on locomotor activity of the horse. Res Commun Chem Path Pharmacol, 35(3):405-419, 1982. |
| 081 | The pharmacology of non-steroidal anti-inflammatory drugs in the horse. III. Flunixin meglumine (Banamine®). Equine Practice, 4(10):16-23, 1982. |
| 082 | Pre-race testing and its role in equine medication control. Equine Vet J, 15(1):54-55, 1983. |
| 083 | Pharmacology, pharmacokinetics, and behavioral effects of caffeine in horse. Am J Vet Res, 44(1):57-63, 1983. |
| 084 | The pharmacology of furosemide in the horse. V. Pharmacokinetics and blood levels of furosemide after intravenous administration. J Drug Metab Disp, 11(3):226-231, 1983. |
| 085 | Toxicoses commonly observed in horses. In Toxicology. Current Therapy in Equine Medicine. Sanders, Philadelphia, 1983, pp 573-615. |
| 086 | Drugs and equine performance: A review. In Snow DH, Persson SGB, Rose RJ (eds): Equine Exercise Physiology, Proc 1st Int’l Conf, Oxford , UK , 1982, pp 510-520. |
| 087 | Effect of urine pH on urine levels of oxyphenbutazone in racing horses. J Drug Metab Dist, 11(6):617-619, 1983. |
| 088 | Phenylbutazone: Its actions, effects, and role in equine medicine. Modern Equine Practice, Jan/Feb 1983, p 25. |
| 089 | Pain perception in the horse and its control by medication: An overview. Proc 5th Int’l Conf, Cont use of drugs in race horses, Toronto, Canada, June 1983, pp 50-51. |
| 090 | Pain: Neurophysiology and experimental equine models. Proc 5th Int’l Conf, Cont use of drugs in race horses, Toronto, Canada, June 1983, pp 52-55. |
| 091 | Phenylbutazone: Lack of effect on normal cutaneous pain perception in the horse. Proc 5th Int’l Conf, Cont use of drugs in race horses, Toronto, Canada, June 1983, pp 85-89. |
| 092 | The pharmacokinetics and blood levels of furosemide after intravenous administration. Proc 5th Int’l Conf, Cont use of drugs in race horses, Toronto , Canada , June 1983, pp 41-49. |
| 093 | Effect of urine pH on urine levels of phenylbutazone, oxyphenbutazone and g-hydroxyphenylbutazone in racing horses. Proc 5th Int’l Conf, Cont use of drugs in race horses, Toronto, Canada, June 1983, pp 26-33. |
| 094 | Clearance times and behavioral effects of clenbuterol in the horse. Proc 5th Int’l Conf, Cont use of drugs in race horses, Toronto , Canada , June 1983, pp 265-271. |
| 095 | Tobin's Testimony on phenylbutazone and furosemide testing before the house subcommittee on criminal justice. The Horsemen's Journal, 34(7):142-149, 1983. |
| 096 | Population distributions of phenylbutazone and oxyphenbutazone after oral and IV dosing in horses. J Vet Phar Therap, 7:265-276, 1984. |
| 097 | Efficacy of testing for illegal medication in horses: A survey. JAVMA, 187:927-930, 1985. |
| 098 | Differential effects of phenylbutazone and local anesthetics on nociception in the equine. Eur J Pharm, 107:35-41, 1985. |
| 099 | Phenylbutazone and its metabolites in plasma and urine of Thoroughbred horses racing in California and Kentucky: Population distributions and the effects of urinary pH. J Vet Pharm Therap, 8:136-149,1985. |
| 100 | Drugs and race-horse performance. Trends in Pharm Sci, 6(3):129-132, 1985. |
| 101 | Effects of phenylbutazone and oxypenylbutazone on basic drug detection in high performance TLC systems. J Vet Pharmacol Therap 8:181-89, 1985 |
| 102 | Plasma and serum concentrations of phenylbutazone and oxyphenbutazone in racing Thoroughbreds 24 hours after various dosage regimens. Am J Vet Res, 46(4):932-938, 1985. |
| 103 | Phenylbutazone levels in post-race samples from horses racing in Kentucky: A review. Proc 4th Symposium on Veterinary Pharmacology and Therapeutics, College Station TX, April 1984, pp 96-115. |
| 104 | A method for studying cutaneous pain perception and analgesia in horses. J Pharm Meth, 13(3):267-274, 1985. |
| 105 | Phenylbutazone in the horse: A review. J Vet Pharmacol Therap, 9:1-25, 1986. |
| 106 | Dose-related effects of fentanyl on autonomic and behavioral responses in performance horses. Gen Pharmacol, 16(3):253-258, 1985. |
| 107 | Dose-related effects of ethylketazocine on nociception, behavior, and autonomic responses in the horse. J Pharm Pharmacol, 38(1):40-45, 1986. |
| 108 | Effects of phenylbutazone and oxypenylbutazone on acicic drug detection in high performance TLC systems. Journal of Pharmaceutical Methods T6:297-313, 1986 |
| 109 | Quantification of equine hoof lameness using an electronic hoof tester. Proc 6th Int’l Conf Racing Analysts Vets. Hong Kong, 1985, pp 325-329. |
| 110 | The effects of kappa-opioid receptor narcotics in the horse: A new class of equine analgesics. 6th Int’l Conf Racing Analysts Vets. Hong Kong, 1985, pp 37-45. |
| 111 | Testing for drugs in horses. J Eq Vet Sci, 6(2):93-97, 1986. |
| 112 | Radioimmunoassay screening for etorphine in racing horses. Res Commun Chem Path Pharmacol, 52(2):237-249, 1986. |
| 113 | Radioimmunoassay screening for etorphine in racing horses. Crone DL (ed) Proc 6th Int’l Conf Racing Analysts Vets., Hong Kong, 1985, pp 199-203. |
| 114 | Experiences as an expert witness: Educating people while under oath. J Eq Vet Sci, 6(3):129-133, 1986. |
| 115 | Efficacy and cost of testing for illegal medications in horses. Proc 6th Int’l Conf Racing Analysts and Vets. Hong Kong, 1985, pp 113-121. |
| 116 | Effects of phenylbutazone and oxyphenbutazone on acidic drug detection in high performance thin layer chromatographic systems. Proc 6th Int’l Conf Racing Analysts and Vets. Hong Kong, 1985 |
| 117 | Influence of urinary pH on concentrations of phenylbutazone and its metabolites in post-race urine samples. Crone DL (Ed) Proc 6th Int’l Conf Racing Analysts and Vets. Hong Kong, 1985, pp 59-68. |
| 118 | Effects of phenylbutazone and oxyphenbutazone on basic drug detection in high performance thin layer chromatographic systems. Proc 6th Int’l Conf Racing Analysts and Vets. Hong Kong, 1985, pp 83-88. |
| 119 | Medication Control: Uncertainty in the "Detection Times" for drugs in horses. J Eq Vet Sci 6(3):124-128, 1986. |
| 120 | Medication Control: Rules. J Eq Vet Sci 6(4):191-195, 1986. |
| 121 | Medication Control: The efficacy and cost of drug testing. Pharmacology 6(6):333-36 |
| 122 | TLC detection of etorphine in equine urines. Crone DL (ed) Proc 6th Int’l Conf Racing Analysts and Vets, Hong Kong, 1985, pp 205-208. |
| 123 | High-sensitivity radioimmunoassay screening method for fentanyl. Am J Vet Res 47(10):2180-2183, 1986. |
| 124 | Pre-purchase testing for drugs in horses: A review. J Eq Vet Sci, 6(1):35-39, 1986. |
| 125 | Dose related effects of kappa agonist U-50,488H on behavior, nociception and autonomic response in the horse. Eq Vet J, 20(2):114-118,1988. |
| 126 | Radioimmunoassay screening for fentanyl in equine and human urine samples with an iodinated fentanyl analog. Proc 40th Meeting Assoc of Racing Chem, Lexington, KY, 141-150, 1986. |
| 127 | Narcotic analgesics, their detection and pain measurement in the horse: A review. Eq Vet J, 21(1):4-12, 1989. |
| 128A | Drugs and performance, part 1. In Equine Sports Medicine, Lea and Febiger, Philadelphia, 1988. pp189-204 |
| 128B | Drugs and performance, part 2. |
| 129 | Hordenine: Pharmacology, pharmacokinetics and behavioural effects in the horse. Eq Vet J, 22(6):437-441, 1990. |
| 130 | Significance of Procaine residues in post race urine samples. Proc 41st Convent Am Assoc. Equine Pract, pp 168-169, 1995. |
| 131 | Radioimmunoassay for etorphine in horses with a 125I analog of etorphine. Am J Vet Res, 49(5):622-628, 1988. |
| 132 | Detomidine: A preliminary analysis of its duration of action in the horse by variable interval responding. Eq Vet J, 20(5):320-322, 1988. |
| 133 | Pharmacologic effects and detection methods of methylated analogs of fentanyl in horses. Am J Vet Res 50(4):502-07 |
| 134 | A review of the pharmacology and detection of fentanyl and its congeners in the horse. Proc 41st Meeting Assoc of Racing Chem., 1987, Los Angeles, CA, pp287-313. |
| 135 | The pharmacology, pharmacokinetics, and behavioral effects of diisopropylamine dichloroacetate (DADA) in the horse: A preliminary report. Gen Pharmacol, 19(5):683-688, 1988. |
| 136 | Immunoassay detection of drugs in horses. I. Particle concentration fluoroimmunoassay detection of fentanyl and its congeners. Res Commun Chem Path Pharmacol, 57(3):389-407, 1987. |
| 137 | Immunoassay detection of drugs in horses. II. Detection of carfentanil in equine urine by RIA, PCFIA and ELISA. Res Commun Subst Abuse, 8(2):59-75, 1987. |
| 138 | Immunoassay detection of drugs in horses. III. Detection of morphine in equine blood by a one step ELISA assay. Res Commun Chem Path Pharmacol, 59(2):259-278, 1988. |
| 139 | Population parameters of equine urine pH and methods of acidification. Proc 7th Int’l Confer Racing Analysts Vets, Louisville, KY, April 1988, 259-265. |
| 140 | Immunoassay detection of drugs in horses. IV. Detection of fentanyl in equine blood and urine by a one step ELISA assay. Res Comm Chem Path Pharmacol, 60(1):97-115, 1988. |
| 141 | Immunoassay detection of drugs in racing horses. V. Detection of mazindol in equine blood and urine by a one step ELISA assay. Res Comm Subst Abuse, 9(1):13-30, 1988. |
| 142 | Operant conditioning and its applications in equine pharmacology. J Equine Vet Sci, 9(3): 124-130, 1989. |
| 143 | Immunoassay detection of drugs in racing horses. VI. Detection of furosemide (Lasix®) equine blood by a one step ELISA and PCFIA. Res Comm Chem Path Pharmacol, 61(1): 111-128, 1988. |
| 144 | Immunoassay detection of drugs in racing horses. VII. Detection of acepromazine in equine blood and urine by ELISA and PCFIA. Res Comm Chem Path Pharmacol, 61(3):391-412, 1988. |
| 145 | Screening for human drugs of abuse by particle concentration fluorescence immunoassay (PCFIA). Res Comm Subst Abuse, 9(3,4):129-155, 1988. |
| 146 | The detection of furosemide in equine blood by fluorescence and enzyme-linked immunoassays. Proc 7th Int’l Confer Racing Analysts Vets, Louisville, KY, April 1988, 113-122. |
| 147 | Enzyme linked immunosorbent assay (ELISA): A revolution in equine drug testing. Equine Veterinary Data, 9(2):19-31, 1988. |
| 148 | Detection of fentanyl and fentanyl derivatives using RIA and ELISA |
| 149 | ELISA detection of morphine in the horse. Proc 7th Int’l Confer Racing Analysts Vets, Louisville, KY, April 1988, 145-153. |
| 150 | ELISA detection of acepromazine in the horse. Proc 7th Int’l Confer Racing Analysts Vets, Louisville, KY, April 1988, 155-160. |
| 151 | Medication Control: The efficacy and cost of drug testing. J Eq Vet Sci 6(6):333-336, 1986. |
| 152 | Immunoassay detection of drugs in racing horses. VIII. Detection of cocaine in equine blood and urine by particle concentration fluorescence immunoassay. Res Comm Subst Abuse, 10(1):1-14, 1989. |
| 153 | Immunoassay detection of drugs in racing horses. IX. Detection of detomidine in equine blood and urine by radioimmunoassay. Res Comm Chem Path Pharm, 63(2):263-279, 1989. |
| 154 | Immunoassay detection of drugs in racing horses. X. Detection of phenylbutazone in equine blood and urine by particle concentration fluoroimmunoassay. Res Comm Subst Abuse, 10(2):123-139, 1989. |
| 155 | Immunoassay detection of drugs in biological samples: XI. ELISA and RIA detection of fentanyl, alfentanil, sufentanil and carfentanil in equine blood and urine. Res Comm Chem Pathol Pharmacol, 63(1):129-152, 1989. |
| 156 | Non-isotopic immunoassay drug tests in racing horses: A review of their application to pre-and post-race testing, drug quantitation, and human drug testing. Res Comm Chem Path Pharm, 62(3):371-395, 1988. |
| 157 | A synthesis of N-substituted beta-alanines: Michael addition of amines to trimethylsilylacrylate. Synthesis, 946-949, 1989. |
| 158 | Immunoassay detection of drugs in racing horses: Detection of ethacrynic acid and bumetanide in equine urine by ELISA. J Analytical Tox, 18: 95-100, 1994. |
| 159 | The effects of drugs on race horse performance. Proc 34th Convent Am Assoc. Equine Pract, San Diego, CA, Dec, 1988, pp 639-650. |
| 160 | Immunoassay based pre-race testing: An effective pre-race testing system. In: Breccia A (ed), Il Controllo Antidoping dei Cavalli da Corsa (Proc Int’l Seminar Tech Pharmacol Legal Aspects Antidoping Control Racehorses). Bologna, Italy, October, 1988, pp 43-52 (145-157). |
| 161 | ELISA based immunoassay tests in post-race testing. In: Breccia A (ed), Il Controllo Antidoping dei Cavalli da Corsa (Proc Int'l Seminar Tech Pharmacol Legal Aspects Antidoping Control Racehorses). Bologna, Italy, October, 1988, pp 85-104 (163-184). |
| 162 | ELISA testing: backgrounds in equine urine, test sensitivity, sample pooling and significance of number of tests. Proc 45th Meeting Assoc Official Racing Chem 308-326, 1992. |
| 163A | Steroidal anti-inflammatory agents and adrenocorticotropic hormones. Equine Pharmacology and Therapy: Proc Eleventh Bain/Fallon Memorial Lectures, presented by Australian Equine Vet Assoc., Coffs Harbor, Australia, pp. 23-30, 1989. |
| 163B | Detection times and clearance times for drugs in racing horses. (Lecture Presentation, Paper from Bain Fallon Lectures) Proceedings of the 76th Annual Convention of the Oklahoma Veterinary Medical Association, pp. 31-37, 1991. |
| 163C | Medication for exercised-induced pulmonary haemorrhage and its effects on other medications. (Lecture Presentation, Paper from Bain Fallon Lectures) Proceedings of the 76th Annual Convention of the Oklahoma Veterinary Medical Association, pp. 43-47, 1991. |
| 163D | Narcotics and stimulants: How they affect horses. (Lecture Presentation, Paper from Bain Fallon Lectures) Proceedings of the 76th Annual Convention of the Oklahoma Veterinary Medical Association, pp. 25-31, 1991. |
| 163E | Steroidal anti-inflammatory agents and adrenocorticotropic hormone. (Lecture Presentation, Paper from Bain Fallon Lectures) Proceedings of the 76th Annual Convention of the Oklahoma Veterinary Medical Association, pp. 19-25, 1991. |
| 163F | Tranquilizers, analgesics and local anaesthetics. (Lecture Presentation, Paper from Bain Fallon Lectures) Proceedings of the 76th Annual Convention of the Oklahoma Veterinary Medical Association, pp. 47-59, 1991 |
| 164 | Medication for exercise-induced pulmonary hemorrhage (EIPH) and its effects on other medications. Equine Pharmacology and Therapy: Proc Eleventh Bain/Fallon Memorial Lectures, presented by Australian Equine Vet Assoc., Coffs Harbor, Australia, pp. 134-141, 1989. |
| 165 | Detection times and clearance times for drugs in racing horses. Equine Pharmacology and Therapy: Proc Eleventh Bain/Fallon Memorial Lectures, presented by Australian Equine Vet Assoc., Coffs Harbor, Australia, pp. 105-113, 1989. |
| 166 | Non-steroidal anti-inflammatory drugs: Phenylbutazone and others. (Lecture Presentation, Paper from Bain Fallon Lectures) Proceedings of the 76th Annual Convention of the Oklahoma Veterinary Medical Association, pp. 13-19, 1991. |
| 167 | Pre- and post-race testing for drugs in racing horses. (Lecture Presentation, Paper from Bain Fallon Lectures) Proceedings of the 76th Annual Convention of the Oklahoma Veterinary Medical Association, pp. 37-43, 1991. |
| 168 | Tranquilizers, analgesics and local anesthetics. Equine Pharmacology and Therapy: Proc Eleventh Bain/Fallon Memorial Lectures, presented by Australian Equine Vet Assoc., Coffs Harbor, Australia, pp. 179-187, 1989. |
| 169 | Anabolic steroids: use and excretion data. Equine Pharmacology and Therapy: Proc Eleventh Bain/Fallon Memorial Lectures, presented by Australian Equine Vet Assoc., Coffs Harbor, Australia, pp. 150-157, 1989. |
| 170 | Narcotics and stimulants: how they affect horses. Equine Pharmacology and Therapy: Proc Eleventh Bain/Fallon Memorial Lectures, presented by Australian Equine Vet Assoc., Coffs Harbor, Australia, pp. 49-59,1989. |
| 171 | The effects of drugs on equine performance and the use of ELISA tests in equine medication control. [Presented to World Equine Vet Assoc. (Equitana), Essen, West Germany, 1989.] J Eq Vet Sci, 9 (3): 160-168, 1989. |
| 172 | Evaluation of threshold doses of drug action in the horse using hematocrit values as an indicator. Res. Comm. Chem. Path. Pharmacol, 75(2):231-241, 1992. |
| 173 | Morphine and etorphine: Detection by ELISA in equine urine. J Analytical Tox, 15(6):305-310, 1991. |
| 174 | Number of negative tests required to exclude specific levels of agent abuse in equine forensic chemistry. Submitted to Equine Practice, 1995. |
| 175 | Clearance times and the forensic significance of the dietary anthelmintic pyrantel tartrate in performance horses. J Eq Vet Sci., 11(4):220-224, 1991. |
| 176 | Immunoassay detection of drugs in racing horses. XIX. Detection of benzoylecgonine(BZE)/cocaine in equine urine by ELISA. Proc 44th Meeting Assoc. Official Racing Chem, Cincinnati, OH, pp. 218-228, 1991. |
| 177 | Development and characterization of an ELISA for cotinine in biological fluids. Inhalation Toxicology, 5(4): 403-413, 1993. |
| 178 | Identification of metabolites of azaperone in horse urine, J Pharm Sci. 85 pp 79-84, 1996. |
| 179 | The dietary anthelmintic pyrantel tartrate: An analysis of its detection times in geldings, mares and stallions. Short CR (ed) Proc 9th Int’l Conf Racing Analysts Vets, New Orleans, LA, 1992, pp 321-326. |
| 180 | 228. Stanley SD, Yang J-M, Wood TW, Selonen JS, Watt DS, Tai H-H, Tobin T: Detomidine clearance in the horse as determined by ELISA. Short CR (ed) Proc 9th Int’l Conf Racing Analysts Vets, New Orleans, LA, 1992, pp 193-201. |
| 181 | ELISA detection of azaperone in the racehorse. Short CR (ed) Proc 9th Int’l Conf Racing Analysts Vets, New Orleans, LA, 1992, pp 187-192. |
| 182 | Development of an ELISA for procaine in racing horses and dogs. Short CR (ed) Proc 9th Int’l Conf Racing Analysts Vets, New Orleans, LA, 1992, pp 377-384. |
| 183 | The development and characterization of an ELISA for trans-3'-hydroxycotinine, a biomarker for mainstream and sidestream smoke exposure. Bengston DA, Henshel DS (eds), Environmental Toxicology and Risk Assessment: Biomarkers and Risk Assessment (5th Vol), Am Soc Testing Materials, Philadelphia, 1996, pp 149-162. [KY Ag Exp Sta #92-4-167] |
| 184 | Exercise-induced pulmonary hemorrhage (EIPH) findings, Proc of Workshop, Part I. Equine Pract, 14(1):19-25, 1992. |
| 185 | Clinical use and characteristics of the corticosteroids. Vet Clin N Amer: Equine Practice, Drug Use in Performance Horses, Vol 9, Saunders, Philadelphia, 1993, pp 543-562. |
| 186 | A review of the Pharmacology, pharmacokinetics, and regulatory control in the US of local anesthetics in the horse. J Vet Pharmacol Therap, 18: pp 397-406, 1995. |
| 187 | Exercise-induced pulmonary hemorrhage (EIPH) findings, Proc of Workshop, Part II. Equine Pract, 14(2):9-15, 1992. |
| 188 | Exercise-induced pulmonary hemorrhage EIPH) findings, Proc of Workshop, Part III. Equine Pract, 14(3):28-31, 1992. |
| 189 | Determination of highest no-effect doses (HNEDs) for the local anesthetic responses to procaine, cocaine, bupivacaine and benzocaine. Equine Vet J, 28:30-37, 1996. |
| 190 | Determination of the local anesthetic efficacy of procaine, cocaine, bupivacaine and benzocaine. Proc 10th Int’l Conf Racing Analysts Vets, Stockholm, Sweden, p. 303-306, 1994. |
| 191 | Equine Drugs and Vaccines: A Guide for Owners and Trainers. Breakthrough Press, Ossining, NY, 1994, 336 pp. |
| 192 | ELISA and RIA detection of fentanyl in the horse. Proc 7th Int’l Confer Racing Analysts Vets, Louisville, KY, April 1988, 123-133. |
| 193 | A review of the methodologies used to determine the highest no-effect doses (HNEDs) for medications in horses. Proc Testing Therap Med Environ Diet Subst Racing Horses, Lexington, KY, 1995, pp 169-174. |
| 194 | Pre- and post-race testing for drugs in racing horses. Equine Pharmacology and Therapy: Proc Eleventh Bain/Fallon Memorial Lectures, presented by Australian Equine Vet Assoc., Coffs Harbor, Australia, pp. 115-124, 1989. |
| 195 | Character and duration of pharmacological effect of isoxsuprine. Proc 41st Convent Am Assoc. Equine Pract, pp 166-167, 1995. |
| 196 | Racing horses, nitroglycerin and exercise-induced pulmonary hemorrhage. Equine Vet J, 27(4):240-241, 1995. |
| 197 | Regulatory significance of procaine residue in plasma and urine samples: Preliminary communication, Equine Vet J, 28(2), 121-125, 1996. |
| 198 | Thresholds for high potency drugs: Plasma or urinary thresholds? Proc Testing Therap Med Environ Diet Subst Racing Horses, Lexington, KY, 1995, pp 185-189. |
| 199 | Frequency distribution of post-race urine pH from thoroughbreds and standardbreds: Research and regulatory significance. Equine Vet J, 27:471-473, 1995. |
| 200 | Interim report on the workshop: Testing for Therapeutic Medications, Environmental and Dietary Substances in Racing Horses, Univ of Kentucky, Lexington, KY, 1994. |
| 201 | Testing for drugs, medications and other substances in racing horses. Proc for the Short Course: Recent Advances in Equine Nutrition, Kentucky Equine Research, Inc., Versailles, KY, 1995, pp 1-26. [KY Ag Exp Sta #95-14-057] |
| 202 | Fifties rules, nineties testing: The need for thresholds for therapeutic medications. Racing Update, 18 (10):89-92, 1995. |
| 203 | Development of a mass spectral confirmation scheme for the carboxylic acid metabolites of detomidine and medetomidine in horse urine. Submitted to Analytical Toxicology, 1992. |
| 204 | Exercise-induced pulmonary hemorrhage (EIPH): A Review of the etiology and pathogenesis. Equine Pract., 19 (1): 22-28, 1997. [KY Ag Exp Sta # 95-14-182] |
| 205 | Effect of a-phenyl-tert-butylnitrone on endotoxin toxemia in horses. Vet Human Toxicol 39 (5) October 1997: pp 268-271. [KY Ag Exp Sta #95-14-077] |
| 206 | Equine Drug Testing: How it works, National HBPA Medication Guide, pp. 42-51, 1998. KY Ag. Exp. Sta. #9814-26 |
| 207 | The effects of steroids in racing horses. Pacemaker Update International, 2: 48, 1989. |
| 208 | An Overview of Dietary, Environmental, and Endogenous Substances of Regulatory Concern in Racing Horses. AAEP Proceedings 41:156-59, 1985 |
| 209 | Amantadine and equine influenza: Pharmacology, pharmacokinetics and neurological effects in the horse. Equine Vet J, 29(2): 104-110, 1997. [KY Ag Exp Sta #95-14-134] |
| 210 | Immobilization of domestic goats (Captra hircus) using orally administered carfentanil citrate and detomidine HCL. J Zoo Wildlife Med, 28 (2): 158-165, 1997. |
| 211 | An overview of the methylxanthines and their regulation in the horse. Equine Practice, 20(1):10-16, 1998. [KY Ag Exp Sta #96-14-084]. |
| 212 | Dietary, environmental, and endogenous substances in horses. In Medication Reference Guide, National Horsemen’s Benevolent & Protective Association, pp 52-58, 1998. |
| 213 | Lack of local anesthetic efficacy of Sarapin in an abaxial sesamoid block model. J Vet Pharmacol Therap 20, 229-232, 1997. |
| 214 | Trace Level Benzoylecgonine (BZE) Identifications in Post-Race Urines: Probable Sources and the Regulatory Significance of Such Identifications. AAEP Proceedings 52:231-36, 2006 |
| 215 | Character and duration of pharmacologic effects of intravenous isoxsuprine. Equine Vet J, 28(4):320-326, 1996. |
| 216 | ELISA assay for caffeine. Proc 11th Intl'n Conf Racing Analysts Vets, Brisbane, Australia, 1996, pp 478-480. |
| 217 | Quantitation of the locomotor effect of therapeutic medication in a behavior chamber. Proc 11th Intl'n Conf Racing Analysts Vets, Brisbane, Australia, 1996, pp 117-120. |
| 218 | Pharmacokinetics and therapeutic efficacy of rimantadine in horses experimentally infected with influenza virus A2. Am J Vet Res, 60:888-894, 1999. [KY Ag Exp Sta #96-14-131]. |
| 219 | ELISA assay for flunixin. Proc 11th Int’l Conf Racing Analysts Vets, Brisbane, Australia, 1996, pp 466-469. |
| 220 | ELISA assay for methocarbamol. Proc 11th Int’l Conf Racing Analysts Vets, Brisbane, Australia, 1996, pp.459-462. |
| 221 | Frequency distributions of pH values in post-race urine samples from Standardbred and Thoroughbred horses. Proc 11th Int’l Conf Racing Analysts Vets, Brisbane, Australia, 1996, pp 442-444. |
| 222 | Passing the test: Immunoassay tests proving fast, reliable in detecting equine drugging. Horseman and Fair World, 9, 52-54, 1989. |
| 223 | Response to a survey among international racing authorities on therapeutic medications, environmental and dietary substances in racehorses. Proc 11th Int’l Conf Racing Analysts Vets, Brisbane, Australia,1996, pp 46-55. |
| 224 | Development and characterization of an equine behavior chamber and the effects of amitraz and detomidine on spontaneous locomotor activity. J Vet Pharmacol Therap, 20:396-401, 1997. |
| 225 | Absence of detectable pharmacological effects after oral administration of isoxsuprine. Equine Vet J 30(4):294-299, 1998. [KY Ag Exp Sta #96-14-142]. |
| 226 | Poisonous plants and feed related poisoning in horses. The Veterinarian’s Practical Reference to Equine Nutrition, 135-165, 1997. |
| 227 | Chemotherapy for equine influenza: Overview of the pharmacology and side effects of amantadine and rimantadine in the horse. Proc 11th Int’l Conf Racing Analysts Vets, Brisbane, Australia, 1996, pp 355-357. |
| 228 | Lidocaine in the horse: Its pharmacological effects and their relationship to analytical findings. J Vet Pharmacol Therap 21:462-476, 1998. |
| 229 | Mepivacaine: Its pharmacological effects and their relationship to analytical finding in the horse. J. Vet. Pharmacol. Therap, 22:107-121, 1999. [KY Ag Exp Sta #98-14-148]. |
| 230 | Ropivacaine in the horse: Its pharmacological responses, urinary detection and mass spectral confirmation. J Vet Pharm Therap, 24:89-98, 2001. [KY Ag. Exp. Sta #98-14-153]. |
| 231 | Characterization of the antinociceptive and sedative effect of amitraz in horses. J Vet Pharmacol Therap, 21(5):400-405, 1997. [KY Ag Exp Sta #97-14-137]. |
| 232 | Medication control from 1900 to the Present. HBPA Medication Booklet, 1998, pp. 23-29. [KY Ag Exp Sta #97-14-138]. |
| 233 | Review of a consequence of highly sensitive drug testing: The need for data on analytical-pharmacological relationships for therapeutic medication. Proc 43rd Convent Am Assoc. Equine Pract, Phoenix, AZ, 1997, pp 215-219. |
| 234 | Bupivacaine in the horse: Relationship of local anaesthetic responses and urinary concentrations of 3-hydroxybupivacaine. J Vet Pharmacol Therap, 22:181-195, 1999. [KY Ag Exp Sta #98-14-166] |
| 235 | Effects of caffeine on locomotor activity of horses: Determination of the no-effect threshold. J Applied Toxicol, 21:229-234, 2001. |
| 236 | Ropivacaine in the horse: its pharmacological responses, urinary detection and mass spectral confirmation. J Vet Pharmacol Therap, 24:89-98, 2001. |
| 237 | Detection and quantitation of 3-hydroxymepivacaine in horse urine. Proc 12th Intl’n Conf Racing Analysts Vets, Vancouver, Canada, 1998, pp324-328. [KY Ag Exp Sta #98-14-35]. |
| 238 | The development of a generic fentanyl ELISA test. Proc 43rd Meeting Assoc. Official Racing Chem, 87, 1990. |
| 239 | Detection and quantitation of 3-hydroxybupivacaine in horse urine. Proc 12th Intl’n Conf Racing Analysts Vets, Vancouver, Canada, 1998, pp287-291. [KY Ag Exp Sta #98-14-48] |
| 240 | Detection, quantification and preliminary pharmacokinetics of diclazuril in the horse. Proc 12th Int’l Conf Racing Analysts Vets, Vancouver, Canada, 1998, pp240-244. [KY Ag Exp Sta #98-14-39]. |
| 241 | Interim report on workshop on equine protozoal myeloencephalitis: Testing and treatment. Manuscript distributed to workshop participants, 1998. [KY Ag Exp Sta #98-14-42]. |
| 242 | Diclazuril in the horse: Its identification, detection and preliminary pharmacokinetics. J Vet Pharm Therap, 22:374-379, 1999. [KY Ag Exp. Sta #98-14-70]. |
| 243 | Inter-laboratory comparison of phenylbutazone quantification |
| 244 | Testing for therapeutic medications: Analytical/pharmacological relationships and the need for “limitations” on the sensitivity of testing for certain agents. J Vet Pharm Therap, 22:220-233. 1999. [KY Ag Exp Sta #98-14-134]. |
| 245 | Lack of local efficacy of fentanyl in the abaxial sesamoid block model. J Vet Pharm Therap, 22:52-55, 1999 [KY Ag Exp Sta #98-14-85]. |
| 246 | Pharmacokinetics and bioavailability of amantadine in the horse. Proc 41st Convent Am Assoc. Equine Pract, Lexington, KY, 1995, pp270-271. |
| 247 | Determination of Highest No-Effect Doses (HNEDs) for local anesthetics. Proc 41st Convent Am Assoc. Equine Pract, pp 163-165, 1995. |
| 248 | Diclazuril and Equine Protozoal Myeloencephalitis. AAEP Proceedings 43:13-14, 1997 |
| 249 | Preliminary pharmacokinetics of diclazuril and toltrazuril in the horse. Proc 43rd Convent Am Assoc. Equine Pract, Phoenix, AZ, 1997, pp15-16. |
| 250 | Development of an equine behavior chamber and effects of amitraz, detomidine and acepromazine on spontaneous locomotor activity. Proc 43rd Convent Am Assoc. Equine Pract, Phoenix, AZ, 1997, pp227-228. |
| 251 | Therapeutic efficacy of rimantadine HCl in experimentally induced influenza: An illness in horses. Proc 43rd Convent Am Assoc. Equine Pract, Phoenix, AZ, 1997, pp390-391. |
| 252 | Equine Drug Metabolites and Standards, 1997 |
| 253 | Pyrilamine in the horse I. Isolation, identification and synthesis of it major urinary metabolite. |
| 254 | Diclazuril and equine protozoal myeloencephalitis. Proc 43rd Convent Am Assoc. Equine Pract, Phoenix, AZ, 1997, pp13-14. |
| 255 | Identification of hydroxyropivacaine glucuronide in equine urine by ESI+/MS/MS. Can J Vet Res, 64(3):178-183. [KY Ag. Exp. Sta#98-14-151]. |
| 256 | The regulation of drugs and medicines in horse racing in the United States. The Association of Racing Commissioners International Uniform Classification of Foreign Substances Guide. J Vet Pharm Therap. 21, 144-153, 1998. |
| 257 | Kentucky Laboratory takes lead against horse dopers. Clin Chem News, 18, pages 1-11, 1992. |
| 258 | Diagnosing equine protozoal myeloencephalitis— complicating factors |
| 259 | An interim report on the Testing Integrity Program seminar “Furosemide in the Horse: Its Actions, Effects and Regulatory Control”. The New Orleans Hilton, Riverside, CA, March, 1998. |
| 260 | Direct MS-MS identification of isoxsuprine-glucuronide in post-adminstration equine urine. Can J Vet Res, 64:112-116, 2000. [KY Ag. Exp. Sta #99-14-3] |
| 261 | Identification of lidocaine and its metabolites in post-administration equine urine by ELISA and MS-MS. J Vet Pharm Therap, 23:215-222, 2000. [KY Ag. Exp. Sta #00-14-91] |
| 262 | An Overview of the Scientific Methods. Booklet Published by Gluck Equine Research Center, Lexington, KY, 1998. [KY Ag. Exp. Sta #98-14-192] |
| 263 | A GC/MS method for the determination of isoxsuprine in biological fluids of the horse utilizing electron impact ionization. Manuscript submitted to J Anal Tox, 2003. |
| 264 | Procedures and quality assurance aspects of the Testing Integrity Program. Submitted to Proceedings of the 52nd Meeting of the Association of Official Racing Chemists, New Orleans, LA, 1999. [KY Ag. Exp. Sta #99-14-27] |
| 265 | Immunoassay detection of drugs in racing horses. Detection of reserpine in equine blood and urine by a one step ELISA. Submitted to Fun App Tox, 1990. |
| 266 | Further characterization of equine isoxsuprine metabolites by electrospray ionization tandem mass spectrometry. Manuscript in preparation, 2003. |
| 267 | Comparison of the quantification of caffeine in human plasma by gas chromatography and ELISA. Braz J Med Biol Res, 34:821-824, 2001. [KY Ag Exp Sta #01-14-116] |
| 268 | Intratracheal clenbuterol in the horse: Its pharmacological efficacy and analytical detection. J Vet Pharmacol Therap, 23:251-260, 2000. [KY Ag. Exp. Sta #99-14-167] |
| 269 | Toltrazuril Sulfone Sodium Salt: Synthesis, Analytical Detection, and Pharmacokinetics in the Horse J Vet Pharmacol Ther 2011 Kentucky Ag Expt Station Number 11-14-046 |
| 270 | Remifentanil in the horse: Identification and detection of its major urinary metabolite. J Analytical Toxicol, 24:309-315, 2000. [KY Ag. Exp. Sta #99-07-145] |
| 271 | Serum concentratins and effects of detomidine delivered orally to horses in three different mediums. Vet Anaesthesia and Analgesia, 29:219-222, 2002. [KY Ag Exp Sta #02-14-018] |
| 272 | Pyrilamine in the horse: II. Detection and pharmacokinetics of pyrilamine and its major urinary metabolite. Manuscript in preparation, 2001. |
| 273 | Influence of electro-acupuncture on pain threshold in horses and its mode of action. Submitted to J Am Vet Med Assoc, 1999. [KY Ag. Exp. Sta # 99-14-170] |
| 274 | Clenbuterol in the horse: Urinary concentrations determined by ELISA and GC/MS after clinical doses. J Vet Pharmacol Therap, 24:7-14, 2001. [KY Ag. Exp. Sta #00-14-49] |
| 275 | Clenbuterol in the horse: Confirmation and quantitation of serum clenbuterol by LC-MS-MS after oral and intratracheal administration. J Analyt Toxicol, 25:280-287, 2001. [KY Ag. Exp. Sta #00-14-122] |
| 276 | Detection and disposition of pyrilamine and its metabolite O-desmethylpyrilamine in equine blood and urine: A preliminary report. Proc 13th Int’l Conf Racing Analysts Vets, Cambridge, UK, 2000, pp472-477. [KY Ag. Exp. Sta # 00-14-85] |
| 277 | Celecoxib in the horse: Its recovery, mass spectrometric identification, disposition and major urinary metabolites. Proc 13th Int’l Conf Racing Analysts Vets, Cambridge, UK, 2000, pp162-170. [KY Ag. Exp. Sta #00-14-101] |
| 278 | A review of Association of Racing Commissioners International class 1, 2 and 3 medication violations and penalties for 1995-1999 in North America. Proc 13th Int’l Conf Racing Analysts Vets, Cambridge, UK, 2000, pp303-309. |
| 279 | The postural signature device: A non-invasive tool for identifying medication thresholds. A preliminary report. Proc 13th Int’l Conf Racing Analysts Vets, Cambridge, UK, 2000, pp46-52. [KY Ag. Exp. Sta #00-14-110] |
| 280 | Identification and detection of the major equine urinary metabolite of remifentanil. Proc 13th Int’l Conf Racing Analysts Vets, Cambridge, UK, 2000, pp465-471. [KY Ag. Exp. Sta #00-14-104] |
| 281 | A highly sensitive LC/MS/MS detection method for clenbuterol in equine serum. Proc 13th Int’l Conf Racing Analysts Vets, Cambridge, UK, 2000, pp420-426. [KY Ag. Exp. Sta #00-14-103] |
| 282 | A liquid chromatographic-electrospray tandem MS/MS method for quantitation of equine cocaine metabolites. Proc 13th Int’l Conf Racing Analysts Vets, Cambridge, UK, 2000, pp413-419. [KY Ag. Exp. Sta #00-14-105] |
| 283 | Fentanyl group ELISA for the detection of remifentanil and other narcotic analgesics. Proc 13th Int’l Conf Racing Analysts Vets, Cambridge, UK, 2000, pp337-340. |
| 284 | Synthesis and characterization of deuterated clenbuterol and two equine metabolites. Proc 13th Int’l Conf Racing Analysts Vets, Cambridge, UK, 2000, 427-429. [KY Ag. Exp. Sta #01-14-8] |
| 285 | Comparison of specific gravity and osmolality in post-race urine of furosemide-treated and control Thoroughbred horses. Proc 13th Int’l Conf Racing Analysts Vets, Cambridge, UK, 2000, pp345-349. |
| 286 | ELISA testing in race horses. Proc. Unione Nazionale L'Incremento Delle Razze Equine. Rome Italy, 1990. |
| 287 | ‘No-effect limits’: An overview and a pharmacological approach. Proc 13th Int’l Conf Racing Analysts Vets, Cambridge, UK, 2000, pp36-42. [KY Ag. Exp. Sta #00-14-198] |
| 288 | ELISA assay for stanozolol. Proc 13th Int’l Conf Racing Analysts Vets, Cambridge, UK, 2000, pp341-344. |
| 289 | The detection and biotransformation of guanabenz in horses: A preliminary report. Vet Ther, 4(2): 197-209, 2003. [KY Ag. Exp. Sta. #01-14-113] |
| 290 | Guanabenz in the horse: Clinical effects and its comparison with other a2 agonists. Manuscript in preparation, 2003. |
| 291 | Equine urine pH: Normal population distribution and methods of acidification. Eq Vet J, 22(2):118-121, 1990. |
| 292 | Detection, quantification, metabolism and behavioral effects of selegiline in the horse. Veterinary Therapeutics, 4(3):257-268, 2003. [KY Ag. Exp. Sta. #01-14-186] |
| 293 | Clinical use and characteristics of the corticosteroids. Vet Clin N Amer: Equine Practice, Drug Use in Performance Horses, Vol 9, Saunders, Philadelphia, 1993, pp 543-562 |
| 294A | New Therapeutic Approaches for Equine Protozoal Myelitis: Synthesis and Pharmacokinetics of Diclazuril Sodium Salt in the Horse: Proceedings of the 15th International Conference of Racing Analysts and Veterinarians, Dubai, pp 135-140 |
| 294B | New Therapeutic Approaches for Equine Protozoal Myeloenchephalitis: Pharmacokinetics of Diclazuril Sodium Salts in Horses. Veterinary Therapeutics 7(1):52-64. |
| 295 | Apparent ELISA detection times for albuterol after administration with the Torpex equine inhaler device. Vet Ther 3(3):297-307, 2002. [KY Ag Exp Sta #02-14-30] |
| 296 | Fragmentation patterns of selected ergot alkaloids by electrospray ionization tandem quadrupole mass spectrometry. J Mass Spec, 39(11):1275-862003. [KY Ag Exp Sta #02-14-60] |
| 297 | Albuterol by Torpex™ and apparent ELISA “detection times”: A preliminary report. In press, Proc 14th Int’l Conf Racing Analysts Vets, Orlando, FL, 2002. |
| 298 | Analytical detection and “normal” population data of cyanide and thiocyanate in equine blood and serum. Proc 14th Int’l Conf Racing Analysts Vets, Orlando, FL, 2002. [KY Ag Exp Sta #02-14-168] |
| 299 | Pharmacodynamics of guanabenz and related α"2 agonists. Proc 14th Int’l Conf Racing Analysts Vets, Orlando, FL, 2002. [Abstract only] |
| 300 | Proposed methodology for the detection of Oxyglobin® in equine plasma. Proc 14th Int’l Conf Racing Analysts Vets, Orlando, FL, 2002. [KY Ag Exp Sta #02-14-169] |
| 301 | Detection, quantification and pharmacokinetics of furosemide in horses: a preliminary report. In press, Proc 14th Int’l Conf Racing Analysts Vets, Orlando, FL, 2002. [Ky Ag Exp Sta #03-14-070] |
| 302 | Diclazuril and equine protozoal myeloencephalitis (EPM)--a clinical report. Equine Vet. Education, 2:258-263, 2000 [KY Ag Exp Sta #98-14-159]. |
| 303 | Stallion influence on reproductive loss during Mare Reproductive Loss Syndrome (MRLS) in Lexington, Kentucky 2001. Abstract submitted to Proc 14th Int’l Conf Racing Analysts Vets, Orlando, FL, 2002. |
| 304 | The effect of intermittent hypoxic training (IHT) on haematological values, aerobic capacity and performance in racing thoroughbreds. Abstract submitted to Proc 14th Int’l Conf Racing Analysts Vets, Orlando, FL, 2002. |
| 305A | Ergot alkaloids screened by electrospray[+] tandem MS/MS |
| 305B | Electrospray[+] tandem quadrupole mass spectrometry in the elucidation of ergot alkaloids chromatographed by HPLC: screening of grass or forage samples for novel toxic compounds. J. Mass Spectrom. 2005; 40: 1484–1502 |
| 306 | A simple, rapid and highly sensitive spectrophotometric method for determination of cyanide in equine biological samples. Toxicology Mechanisms and Methods 13:129-138, 2003. [KY Ag Exp Sta# 02-14-85] |
| 307A | The toxicokinetics of cyanide and mandelonitrile in the horse and their relevance to the Mare Reproductive Loss Syndrome. Toxicology Mechanisms and Methods, 13:199-211, 2003. [KY Ag Exp Sta# 02-14-86] |
| 307B | The pharmacokinetics of cyanide and mandelonitrile in the horse and their relevance to the Mare Reproductive Loss Syndrome. Proc 14th Int’l Conf Racing Analysts Vets, Orlando, FL, 2002. [KY Ag Exp Sta #03-14-071] |
| 308 | The Kentucky 2001 mare reproductive loss syndrome (MRLS): overview and preliminary toxicological approaches |
| 309 | Final summary report: Identification of appropriate standards for corrective action for a release from petroleum underground storage tanks. Submitted to Petroleum Underground Storage Tank Environmental Assurance Fund Commission, 1995. Sendlein LVA, Birge WJ, Blomquist GC, Dinger JS, Huffsey RR, Horstman SW, Kercher MD, McGinley P, Short DC, Struttman T, Taylor L, Tobin T, Dunn D, Naugle BI: |
| 310 | Determination of the Highest No-effect Dose (HNED) and of the elimination pattern for cocaine in horses. J Appl Toxicol 22:117-121, 2002. [KY Ag Exp Sta #02-14-156] |
| 311 | MRLS and Associated Syndromes: Toxicological Hypotheses (Tobin proposes septic setal emboli hypothesis). In Proc First 1st Workshop on Mare Reproductive Loss Syndrome, Lexington, KY, 2002, p75. |
| 312 | Detection of selegiline and selegiline metabolites in an ELISA assay for amphetamine. Manuscript submitted to Proc 14th Int’l Conf Racing Analysts Vets, Orlando, FL, 2002. |
| 313 | ELISA assay for ketamine. Manuscript submitted to Proc 14th Int’l Conf Racing Analysts Vets, Orlando, FL, 2002. |
| 314 | ELISA assay for guanabenz. Manuscript submitted to Proc 14th Int’l Conf Racing Analysts Vets, Orlando, FL, 2002. |
| 315 | ELISA assay for apomorphine. Manuscript submitted to Proc 14th Int’l Conf Racing Analysts Vets, Orlando, FL, 2002. |
| 316 | Cherry trees, plant cyanogens, caterpillars and Mare Reproductive Loss Syndrome [MRLS]: Toxicological evaluation of a working hypothesis. In Proc First Workshop on Mare Reproductive Loss Syndrome, Lexington, KY, 2002, pp68-74. [KY Ag Exp Sta # 02-14-167] |
| 317 | The detection, quantification and pharmacokinetics of furosemide and its effects on urinary specific gravity following intravenous administration to horses. Manuscript in press, Veterinary Therapeutics, 2003. [KY Ag. Exp. Sta. #03-14-104] |
| 318 | Blood plasma concentrations of insulin-like growth factor-1 (IGF-1) in resting standardbred horses. The Vet J 163:45-50, 2002. |
| 319 | Experimentally Induced Mare Reproductive Loss Syndrome [MRLS] Late Fetal Losses with Eastern Tent Caterpillars. In Powell DG, Troppman A, Tobin T (eds), Proc First Workshop on Mare Reproductive Loss Syndrome, Lexington, KY, 2002, pp80-81. |
| 320 | A laboratory animal model of Mare Reproductive Loss Syndrome [MRLS]: preliminary evaluation of a mouse model. In Powell DG, Troppman A, Tobin T (eds), Proc First Workshop on Mare Reproductive Loss Syndrome, Lexington, KY, 2002, pp51-53. |
| 321 | Effect of furosemide on urine specific gravity and osmolality in Thoroughbred racehorses. Veterinary Therapeutics, 4(3):292-298, 2003. [Ky Ag Exp Sta # 02-14-180] |
| 322 | Development of a method for the detection and confirmation of the "α2-agonist amitraz and its metabolites in horse urine. Manuscript accepted by J Anal Tox, 2003. |
| 323 | Septic Penetrating Setae/Septic Emboli/Septic Penetrating Setal Emboli (SPS/SE/SPSE): A hypothesis to explain the pathogenesis of the Mare Reproductive Loss Syndrome. Copyright registered at Library of Congress, June 17, 2003, #TXU1111484. |
| 324A | Metabolism of the beta-agonist ractopamine in the horse |
| 324B | Detection and confirmation of ractopamine and its metabolites in horse urine after Paylean® administration. J Anal Tox, 2004. [KY Ag Exp Sta # 03-14-041] |
| 325 | The past and future of equine drug testing and medication regulation. 24th Bain-Fallon Lectures, 2002 |
| 326A | Factors affecting "detection times" and "withdrawal times" for NSAIDS. 24th Bain-Fallon Lectures, 2002 |
| 326B | The Mare Reproductive Loss Syndrome: an ongoing toxicological/other investigation. Submitted to Proc 24th Bain-Fallon Memorial Lectures, Gold Coast, Australia, 2002. |
| 327 | Pre-purchase, and drug testing of horses: a review. 24th Bain-Fallon Lectures, 2002 |
| 328 | US Patent Application — Guanabenz: a newly identified equine and veterinary sedative, tranquilizer, and analgesic |
| 329 | Cocaine hepatotoxicity: influence of hepatic enzyme inducing and inhibiting agents on the site of necrosis. Hepatology. 15(5):934-40, 1992. |
| 330 | National Horsemen’s Benevolent and Protective Association, Inc. Proposed National Policy on Drug Testing and Therapeutic Medication Regulation. J Eq Vet Sci 23(1): 4-5, 18-40, 2003. [Ky Ag Exp Sta# 03-14-072] --- Superceeded by 2012 book. |
| 331 | Mare Reproductive Loss Syndrome (MRLS) and the eastern tent catapillar: a toxicokinetic/statistical analysis with clinical, epidemiologic, and mechanical implications. J Vet Therap 4(4):324-39, 2005. |
| 332 | Detection of selegiline and its major urinary metabolite, N-desmethylselegiline, in equine urine: A preliminary report. Submitted to Proceedings of the 54th Meeting of the Association of Official Racing Chemists, Lexington, KY, 2001. [KY Ag Exp Sta #01-14-186] |
| 333 | Overview of dietary, environmental, and endogenous substances of regulatory concern in racing horses. Proc 41st Convent Am Assoc Equine Pract, Lexington, KY, 1995, pp156-159. |
| 334 | Test of time — ELISA testing. The Blood Horse, November 17, 1990, pp. 6188-6190. |
| 335 | An overview of the effective world rules on therapeutic medications — Superceeded by the 2012 book. |
| 336 | Metabolism of the α2-agonist amitraz in horses and confirmation of its administration, Proc 15th Intl Conf Racing Analysts Vets, pp. 155-160 [KY Ag Exp Sta #04-14-010]. |
| 337 | Metabolism of the beta-adrenergic agonist ractopamine in horses and confirmation of its administration with GC/MS. 15th Intl Conf Racing Analysts Vets, pp.93-98 [KY Ag Exp Sta #04-14-008] |
| 338 | A toxicokinetic/Accelerated Failure Time Analysis of the Mare Reproductive Loss Syndrome (MRLS). Proc 15th Intl Conf Racing Analysts Vets, 2004. p212-217 [KY Ag Exp Sta #04-14-020] |
| 339 | Septic Penetrating Setae/Bacteria/Bacterial Emboli/Septic Penetrating Setal Emboli (SPS/B/BE/SPSE): A hypothesis to explain the pathogenesis of Mare Reproductive Loss Syndrome [MRLS]. 15th Intl Conf Racing Analysts Vets, p. 418-422 , 2004. |
| 340 | Preliminary report on the confirmation and quantitative determination of salmeterol in equine urine. Proc 15th Intl Conf Racing Analysts Vets, 2004. p. 406-411[KY Ag Exp Sta #04-14-009] |
| 341 | Synthesis and certification of salmeterol and salmeterol-d12 standards. Proc 15th Intl Conf Racing Analysts Vets, 2004. p405 |
| 342 | The mare reproductive loss syndrome (MRLS) and the eastern tent caterpillar II. A toxicokinetic/ clinical evaluation and proposed pathogenesis: septic penetrating setae. |
| 343 | US Patent 5,883,095 — Formulations and methods to treat and prevent EPM —clazuril, diclazuril, toltrazuril |
| 344 | US Patent 4,473,640 — Detection of morphine and its analogues using enzymatic hydrolysis with ß-glucuronidase. |
| 345 | ELISA testing of racing horses. an overview. (slide presentation) |
| 346 | Detection and identification of dizocilpine and its major urinary metabolites in the horse: a preliminary report. Chromatographia 59:S95-S103, 2004. [KY Ag Exp Sta #04-14-003] |
| 347 | Determination of salmeterol in equine urine and serum. Chromatographia 59:S79-S84, 2004. [KY Ag Exp Sta# 04-14-011] |
| 348 | Cyanide in the horse: Normal blood concentrations and their elevation, monitoring, and manipulation. (Abstract) |
| 349 | Number of negative tests required to exclude specified levels of agent abuse in equine forensic chemistry. Manuscript in progress, 2004. |
| 350 | Preparation and Chromatographic Characterization of tetrahydrogestrinone (THG), a New “designer” Anabolic Steroid. Chromatographia, 60, 359-363. [KY Ag Exp Sta #04-14-052 |
| 351 | Chromatographic detection of trimetoquinol (Inolin®) and its major urinary metabolites in the horse: a preliminary report |
| 352 | US Patent for the control or eastern tent caterpillars |
| 353 | Preparation and analysis of tetrahydrogestrinone (THG), a recently reported “designer” anabolic steroid. Proc 15th Intl Conf Racing Analysts Vets,.p518-522 |
| 353.5 | Preparation and chromatographic characterization of tetrahydrogestrinone, a new "designer" anabolic steroid. Chromatographia. 2004, 60, 359–363 |
| 354 | An overview of analytical/pharmacological relationships and the need for limitations on the sensitivity of testing for certain agents. Proc 12th Int’l Conf Racing Analysts Vets, Vancouver, Canada, 1998, pp210-216. [KY Ag Exp Sta #98-14-50] |
| 355 | Enzyme Linked Immunoassay Drug Testing (ELISA) The Blood-Horse, Jan 1988 |
| 356 | ELISA Testing. The Blood-Horse, Sep 1988 |
| 357 | Experiences as an expert witness — 25 years since Hong Kong |
| 358 | Review of Environmental Morphine Identifications: World wide occurrences and Responses of Authorities. AAEP Proc. vol. 61 p58-64 |
| 359 | Drugs, Medications, and Performance Altering Substances: Their Performance Effects, Detection and Regulation: From 1800 to Keenland Oct 12th 2005 |
| 360 | Intravenous and intratracheal administration of trimetoquinol, a fast-acting short-lived bronchodilator in horses with 'heaves'. Equine Vet J. 38(6):563-9 |
| 361 | Analysis of prohibited substances in Kentucky with emphasis on strategies for practitioners to avoid problems. Proc 41st Convent Am Assoc Equine Pract, Lexington, KY, 1995, pp160-162. |
| 362 | Trimetoquinol: bronchodilator effects in horses with heaves following aerosolised and oral administration. Equine Vet J. 39(3):215-20 |
| 363 | Caffeine and Theobromine Identifications in Post race Urines: Threshold Levels and Regulatory Significance of Such Identifications. AAEP Proc. Vol. 53 p87-92. |
| 364 | Plasma and urinary concentrations of trimetoquinol by LC-MS-MS following intravenous and intra-tracheal administration to horses with heaves. J Vet Pharmacol Ther 31(6):501-10 |
| 365 | Gabapentin in horses: validation of an analytical method for gabapentin quantitation. J Anal Toxicol. 31(9):555-65 |
| 366 | ESI+MS/MS confirmation of canine ivermectin toxicity. J Mass Spectrom.44(1):1119. |
| 367 | Pharmacokinetics of gabapentin in horses. J Vet Pharmacol Ther. 31(2):175-7, 2008 |
| 368 | Detection, quantification and confirmation of anabolic steroids in equine plasma by liquid chromatography and tandem mass spectrometry. Journal of Chromatography B 829 56–68. |
| 369 | Review of the Current Status of Thresholds/Withdrawal Time Guidelines for Therapeutic Medications in Performance Horses. AAEP proc. Vol.54 p29-37 |
| 370 | Nonsteroidal anti-inflammatory agents and musculoskeletal injuries in Thoroughbred racehorses in Kentucky J. vet. Pharmacol. Therap. doi: 10.1111/j.1365-2885.2008.01038.x |
| 371 | Synthesis of deuterated analytical standards: Ketoprofen-d3 and Flunixin-d3. Proceedings of the 16th International Conference of Racing Analysts and Veterinarians, Tokyo, Japan, pp214-217 |
| 372 | New therapeutic approaches to equine protozoal myeloencephalitis: Clinical pharmacology and apparent efficacy of diclazuril, toltrazuril and sulfonotoltrazuril. Submitted to J Vet Pharmacol Therap, 2001. [KY Ag. Exp. Sta #00-14-102] |
| 373 | Pyrilamine in the horse: Detection and pharmacokinetics of pyrilamine and its major urinary metabolite “O-desmethylpyrilamine”. J Vet Pharmacol Ther. 2009 Feb;32(1):66-78 |
| 374 | Serum concentrations of ergovaline/ ergot alkaloids in late-term pregnant mares grazing entophyte infected tall fescue pastures: A preliminary report. Theriogenology 70 (2008) p583 |
| 375 | Serum concentrations of ergovaline and ergot alkaloids in horses grazing entophyte positive pastures |
| 376A | Corrupt Horseracing Practices — 1983 US House Hearing. Part 1 |
| 376B | Corrupt Horseracing Practices — 1983 US House Hearing. Part 2 |
| 377 | Short Communication: A rapid and sensitive Enzyme Linked ImmunoSorbent Assay (ELISA) test for guanabenz in the horse. Manuscript in preparation, 2003. |
| 378 | National HBPA Medication Policy Document, October 2001 — Superceeded by 2012 book. |
| 379 | Tramadol in the Horse: A Preliminary Report on its Detection, Pharmacokinetics and Pharmacodynamics Responses. Proceedings of the 17th International Conference of Racing Analysts and Veterinarians, Antalya, Turkey, pp 106-115. |
| 380 | Intravenous Tramadol: Effects, Nociceptive Properties, and Pharmacokinetics in Horses. Veterinary Anaesthesia and Analgesia 36, 581-590. |
| 381 | Synthesis and Detection Of Toltrazuril Sulfone and Its Pharmacokinetics In Horses Following Administration In Dimethylsulfoxide. J Vet Pharmacol Ther. 2009 Aug; 32(4):368-78 |
| 382 | Pemoline and Tetramisole “Positives” In English Racehorses Following Levamisole Administration. Irish Vet J 63(8):498-500, 2010 |
| 383 | Effect of Dimethylsulphoxide (DMSO) On Oral bioavailability Of a Triazine Based Antiprotozoalagent Toltrazuril Sulfone In The Horse. Proceedings of the 17th International Conference of Racing Analysts and Veterinarians, Antalya, Turkey. pp.315-320 |
| 384 | Nonsteroidal Anti-Inflammatory (NSAID) Agents And Musculoskeletal Injuries In Thoroughbred Racehorses In Kentucky. Proceedings of the 17th International Conference of Racing Analysts and Veterinarians, Antalya, Turkey. pp 329-333 |
| 385 | Cómo evitar resultados positivos en el doping: las reglas de la via terapéutica. 3rd Congreso Mundial Equino Confepaso |
| 386 | Certified Reference Standards and Stable Isotope Internal Standards for Equine Therapeutic Medication Regulation. In press, Proceedings of the 18th International Conference of Racing Analysts and Veterinarians,Queens Town, New Zealand |
| 387 | Clinically effective loading dose schedule for Ponazuril® in the horse |
| 388 | “Shipping In” A Risk Factor Associated with Fatal Musculoskeletal Racing Injuries. Submitted for publication, |
| 389 | Evaluation of mass spectrometric methods for detection of the anti-protozal drug imidocarb. Journal of Analytical Toxicology 35:199-204, 2011 |
| 390 | Race for the Prize -- interview with Thomas Tobin in The Irish Vet Journal. Aug 2010 |
| 391 |
The mare reproductive loss syndrome and the eastern tent caterpillar II: a toxicokinetic/clinical evaluation and a proposed pathogenesis: spetic penetrating setae. Int. J. Appl. Res. Vet. Med., 2 (2004), pp. 142–158 |
| 392 | Polymorphism in 2-(4-hydroxy-2,6-dimethylanilino)-5,6-dihydro-4H-1,3-thiazin-3-ium chloride. Acta Crystallographica Sec. C: Crystal Structure Communications C66:o595-96, 2011 |
| 393 | Equine protozoal myeloencephalitis (EPM): causative agents, clinical signs, current therepeutic approaches |
| 394 | Solvatomorphism in (E)-2-(2,6-di-chloro-4-hydroxybenzylidene)-hydrazinecarboximidamide. Acta Chrystallographica C67:o310-14, 2011 |
| 395 | Diclazuril protects against maternal gastrointestinal syndrome and congenital toxoplasmosis. Int J Clin Med, 2014, 5:93-101 |
| 396 | ESI-Mass spectrometric and HPLC elucidation of a new ergot alkaloid from perennial ryegrass hay silage associated with bovine reproductive problems, In press, Toxicology Mechanisms and Methods, 2011 KAES Article # 11-14-031 UK # 396. |
| 397 | Toltrazuril sulfone: synthesis, detection, and pharmacokinetics in the horse. J Vet Pharmacol Therap |
| 398 | Synthesis of myo-inositol trispyrophosphate (ITPP) for use as an analytical standard. Proceedings 19th International Conference of Racing Analysts and Veterinarians, Philadelphia, Pennsylvania, September 15-22, 2012 |
| 399 | Furosemide, the Prevention of Epistaxis and Related Considerations: A Preliminary Evaluation:. Intern J Appl Res Vet Med. Vol 10(2), 2012. pp176-185. |
| 400 | Foreign substances reported in Iowa racing, 2001 – 2011: a review and analysis, Submitted for presentation and publication, American Association of Equine Practitioners Annual Convention, Anaheim, CA. December 3. 2012. |
| 401 | Cathinone and related "Bath Salt" substances — detection in equine urine and potential sources. Proceedings 19th International Conference of Racing Analysts and Veterinarians. Philadelphia, Pennsylvania, September 15-22, 2012 |
| 402 | Synthesis of 3-hydroxymepivacaine-d3 as an internal standard for equine medication regulation. Proceedings 19th International Conference of Racing Analysts and Veterinarians. Philadelphia, Pennsylvania, September 15-22, 2012 |
| 403 | A clinicians guide to factors affecting withdrawal times for equine therapeutic medications. The Veterinary Journal. 2013 |
| 404 | Furosemide, Epistaxis and the Racing Horse: A review and Analysis: in progress, invited review for The Veterinary Journal |
| 405 | Atovaquone ameliorated gastrointestinal toxoplasmosis complications in a pregnancy model. Med Sci Monit 18(9):BR337-45 |
| 406 | A toxicogy and clinical study of post race epistaxis associated with exercise induced pulmonary hemorrhage (EIPH) in Thoroughbred race horses a the Racecourse Rinconada, Caracas, Venezuela. 1:348. doi:10.4172/scientificreports.348 |
| 407 | Current therapeutic approaches to equine protozoal myeloencephalitis. J Am Vet Med Assoc. 2013, Vol. 242, No. 4, pp 482-91 |
| 408 | Bovine Colostrum supplementation does not influence serum IGF-1 in horses in race training, Submitted March 2013 for publication in The Veterinary Journal. |
| 409 | Bovine Colostrum supplementation decreases the incidence of upper respiratory infection in horses in race training and may improve performance and recovery; Submitted for presentation and publication, Proceedings of the 59th AAEP Annual Convention, Nashville, Tennessee December 2013, |
| 410 | An overview of the effective world rules on therapeutic medications. Booklet published by Gluck Equine Research Center. — Superceeded by 2012 book. |
| 411 | Iron - its functions and metabolism in the horse. Equine Sports Med News 1984 4(2):1-3 |
| 412 | World Rules for Equine Drug Testing and Therapeutic Medication Regulation; 2012 Policy of the National Horsemen's Benevolent and Protective Association, Inc. Wind Publications, 600 Overbrook Dr, Nicholasville, KY 40356, USA pp 370 KAES Article # 11-014-096 |
| 413 | Synthesis, purification, chemical characterization of 20-dihydro-6-methylprednisone, an isomeric metabolite of methylprednisolone in the horse. Drug Testing and Analysis 6(3):303–07, March 2014 |
| 414 | Diclazuril:
safe and highly effective fetal protection in a mouse model of
fetal/congenital toxoplasmosis |
| 415 | Scopolamine in racing horses: trace identifications associated with dietary or environmental exposure. A review. The Veterinary Journal. |
| 416 | Sudden death in the Throughbred horse at Racetrack La Rinconada, Caracas-Venezeula. Presented at the Congreso Internacional de Medicina y Cirugía Equina 2013: Muerte Subita en Caballos Pura Sangre Ingles Decarrera Hipodromo “La Rinconada” Caracas-Venezeula. |
| The mare reproductive loss syndrome (MRLS) and the eastern tent caterpillar: immunological testing of aborting mares. Intern J Appl Res Vet Med. 2005, 3(3):207-216 | |
| 418 |
Deteccion de Furosemida y Otras Substancias en Caballos de Carrera. (Detection of furosemide and other substances in race horses) Presented at 5th Simpósio da Associação Latinoamericana de Patologia Toxicológica, 13 April 2014, São Paulo, Spain. |
| 419 | Cobalt use and regulation in horse racing: A review. (submitted for publication) |
| 420 | Increased incidence of sudden death associated with exercise induced pulmonary hemorrhage (EIPH) in horses racing at higher altitude in Venezuela. Proceedings of the 20th Int Conf of Racing Analysts and Veterinarians. 2014. |
| 421 | 20-Dihydro-6-methylprednisone, an isomeric metabolite of methylprednisolone: synthesis of an analytical standard Proceedings of the 20th Int Conf of Racing Analysts and Veterinarians. 2014. |
| 422 | Dihydoprednisone, an isomeric metabolite of prednisolone: synthesis of an analytical standard Proceedings of the 20th Int Conf of Racing Analysts and Veterinarians. 2014. |
|
423 |
Tramadol: A human therapeutic medication and an environmental substance occasionally identified in equine drug testing. Submitted to The Veterinary Journal |
|
424 |
An unusual cluster of low concentration methamphetamine identifications in racing horses associated with a methamphetamine-contaminated horse trailer: a report and analysis (submitted for publication) |